Special Issue "Non-coding RNAs and COVID-19"

A special issue of Non-Coding RNA (ISSN 2311-553X).

Deadline for manuscript submissions: 31 March 2022.

Special Issue Editors

Dr. Gaetano Santulli
E-Mail Website
Guest Editor
1. Department of Medicine, Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Albert Einstein College of Medicine, New York, NY 10461, USA
2. Department of Advanced Biomedical Science, “Federico II” University, and International Translational Research and Medical Education Consortium (ITME), 80131 Naples, Italy
3. Department of Molecular Pharmacology, Albert Einstein College of Medicine, New York, NY 10461, USA
Interests: cardiology; hypertension; restenosis; heart failure; myocardial infarction; endothelial dysfunction; mitochondria; diabetes; microRNAs; insulin resistance; atherosclerosis; thrombosis; cardiac hypertrophy; pancreatic beta cell function; insulin release
Special Issues and Collections in MDPI journals
Dr. Jessica Gambardella
E-Mail Website
Guest Editor
Department of Molecular Pharmacology, Albert Einstein College of Medicine - Montefiore University Hospital, 1300 Morris Park Avenue, New York, NY 10461, USA
Interests: molecular biology; calcium; endothelium; mitochondria; heart diseases; microRNAs

Special Issue Information

Dear Colleagues,

Recent evidence has shown that non-coding RNAs could be implemented in the pathophysiology of the systemic manifestations of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2).

On these grounds, this Special Issue of Non-Coding RNA has the main objective to gather high-quality research papers that have a solid basic research setting and/or translational potential on this topic. Therefore, studies exploring the mechanistic role of non-coding RNAs in the pathophysiology of COVID-19 and its complications are especially welcome in this Special Issue. We are interested in both clinical and pre-clinical investigations testing novel hypotheses that can advance the field. Novel therapeutic hypotheses and medicinal chemistry endeavors toward novel drug development are also encouraged.

In this Special Issue, we are making a call to action to stimulate researchers to submit their invaluable studies on non-coding RNAs and COVID-19. Original investigations, as well as review articles, are welcome. In summary, this Special Issue aims to underscore the key importance of non-coding RNAs in COVID-19.

Prof. Dr. Gaetano Santulli
Dr. Jessica Gambardella
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Non-Coding RNA is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • COVID-19
  • RNA biology
  • microRNA
  • lncRNA
  • circular RNA
  • SARS-CoV-2
  • exosomes
  • virus
  • vaccine
  • epigenetics
  • biomarkers
  • epitranscriptomics
  • bioinformatics

Published Papers

This special issue is now open for submission.
Back to TopTop